Growing community of inventors

Olathe, KS, United States of America

Deepak Phadke

Average Co-Inventor Count = 2.54

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 46

Deepak PhadkeNatalie M Platt (8 patents)Deepak PhadkeRavi K Pandrapragada (8 patents)Deepak PhadkeMihael Hristos Polymeropoulos (5 patents)Deepak PhadkeMarlene Michelle Dressman (4 patents)Deepak PhadkeChristian Lavedan (1 patent)Deepak PhadkeCurt Douglas Wolfgang (1 patent)Deepak PhadkeJohn Joseph Feeney (1 patent)Deepak PhadkePaul F Skultety (1 patent)Deepak PhadkeThomas T Ortyl (1 patent)Deepak PhadkeKristen C Mitchell (1 patent)Deepak PhadkeFaraneh Attarchi (1 patent)Deepak PhadkeAaron W Schoeneman (1 patent)Deepak PhadkeJoseph M Schnitz (1 patent)Deepak PhadkeMarguerite L Pierce (1 patent)Deepak PhadkeGunther Birznieks (1 patent)Deepak PhadkeDeepak Phadke (19 patents)Natalie M PlattNatalie M Platt (8 patents)Ravi K PandrapragadaRavi K Pandrapragada (8 patents)Mihael Hristos PolymeropoulosMihael Hristos Polymeropoulos (77 patents)Marlene Michelle DressmanMarlene Michelle Dressman (30 patents)Christian LavedanChristian Lavedan (26 patents)Curt Douglas WolfgangCurt Douglas Wolfgang (18 patents)John Joseph FeeneyJohn Joseph Feeney (16 patents)Paul F SkultetyPaul F Skultety (10 patents)Thomas T OrtylThomas T Ortyl (6 patents)Kristen C MitchellKristen C Mitchell (5 patents)Faraneh AttarchiFaraneh Attarchi (5 patents)Aaron W SchoenemanAaron W Schoeneman (5 patents)Joseph M SchnitzJoseph M Schnitz (5 patents)Marguerite L PierceMarguerite L Pierce (4 patents)Gunther BirznieksGunther Birznieks (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Vanda Pharmaceuticals Inc. (18 from 108 patents)

2. Aventisub II Inc. (1 from 23 patents)


19 patents:

1. 12447141 - Liquid tasimelteon formulations and methods of use thereof

2. 12440470 - Liquid tasimelteon formulations and methods of use thereof

3. 12304896 - Highly purified pharmaceutical grade tasimelteon

4. 12049457 - Highly purified pharmaceutical grade tasimelteon

5. 11760740 - Highly purified pharmaceutical grade tasimelteon

6. 11759446 - Liquid tasimelteon formulations and methods of use thereof

7. 11566011 - Highly purified pharmaceutical grade tasimelteon

8. 11203581 - Highly purified pharmaceutical grade tasimelteon

9. 11202770 - Liquid tasimelteon formulations and methods of use thereof

10. 10874659 - Iloperidone metabolite for use in the treatment of psychiatric disorders

11. 10829465 - Highly purified pharmaceutical grade tasimelteon

12. 10611744 - Highly purified pharmaceutical grade tasimelteon

13. 10233142 - Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

14. 10071977 - Highly purifid pharmaceutical grade tasimelteon

15. 9850199 - Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…